Microorganisms have an unbounded potential when it comes to converting bio-sourced feedstocks or industrial waste into bio-based molecules meeting every application’s standard. The selection, development and optimization of strains are inevitable to initiate any viable industrial process aiming at producing a bio-based compound.
As part of Lesaffre, we leverage our large bank of yeast, bacterial and fungal strains as well as our Biofoundry hosted in France. This allows for the screening and selection of the most relevant host adapted to industrial conditions. To meet the specific needs of microorganism development for the production of new bio-based molecules for green chemistry, we are able to develop strains with new functionalities – such as enzyme production or glycerol reduction. At Recombia Biosciences, a new entity founded in 2019 based on technology licensed from Stanford University and acquired by Lesaffre in 2022, we accelerate genetic modifications with the highest precision, while using proprietary techniques.
Reaching the best KPIs – yield, productivity, and titer – with a high production stability at industrial scale, despite the intrinsic variability of biotechnological processes is at the core of sustainable bio-based productions. Understanding this challenge, as well as the need to master industrial substrates while reducing the production of high-impact effluents, co-product, or residues, allows us to deliver viable and reliable microorganisms perfectly adapted to the conditions of a given process at industrial scale.
We combine multiple resources and skills to serve our partners in their bio-based journey: from a relevant strain bank to a broad range of applications in multiple fermentation industries and advanced R&D infrastructures.